Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
CST Brands Inc. (NYSE: CST) shares declined 0.38 percent to close at $31.42 a share Tuesday. The stock traded between $30.89 and $31.80 on volume 761,847 shares traded. Analysts at Credit Suisse have initiated coverage on the company with an “underperform” rating and a price target of $29.00. Shares of CST Brands have fallen approximately 14.0 percent year-to-date.
Find out more about CST Brands including full access to the free equity report at:
Harsco Corporation (NYSE: HSC) shares increased 1.74 percent to close at $25.12 a share Tuesday. The stock traded between $24.86 and $25.27 on volume of 557,930 shares traded. Analysts at Argus have recently upgraded the company’s rating to “buy” from “hold”. Shares of Harsco have fallen approximately 10.0 percent year-to-date.
Find out more about Harsco including full access to the free equity report at:
Novo Nordisk (NYSE: NVO) shares increased 5.26 percent to close at $48.23 a share Tuesday. The stock traded between $47.08 and $48.42 on volume of 3.59 million shares traded. Analysts at Bank of America Merrill Lynch have recently upgraded the company’s rating to “buy” from “neutral”. Shares of Novo Nordisk have gained approximately 30.0 percent year-to-date.
Find out more about Novo Nordisk including full access to the free equity report at:
TiVo Inc. (NASDAQ: TIVO) shares increased 1.15 percent to close at $13.17 a share Tuesday. The stock traded between $13.07 and $13.25 on volume of 1.52 million shares traded. Analysts at Northland Securities have recently initiated coverage on the company with an “outperform” rating and a price target of $15.00. Shares of TiVo have gained approximately 8.0 percent in the past month.
Find out more about TiVo including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing